| Literature DB >> 17317574 |
Huw D Lewis1, Matthew Leveridge, Peter R Strack, Christine D Haldon, Jennifer O'neil, Hellen Kim, Andrew Madin, Joanne C Hannam, A Thomas Look, Nancy Kohl, Giulio Draetta, Timothy Harrison, Julie A Kerby, Mark S Shearman, Dirk Beher.
Abstract
In this report, inhibitors of the gamma-secretase enzyme have been exploited to characterize the antiproliferative relationship between target inhibition and cellular responses in Notch-dependent human T cell acute lymphoblastic leukemia (T-ALL) cell lines. Inhibition of gamma-secretase led to decreased Notch signaling, measured by endogenous NOTCH intracellular domain (NICD) formation, and was associated with decreased cell viability. Flow cytometry revealed that decreased cell viability resulted from a G(0)/G(1) cell cycle block, which correlated strongly to the induction of apoptosis. These effects associated with inhibitor treatment were rescued by exogenous expression of NICD and were not mirrored when a markedly less active enantiomer was used, demonstrating the gamma-secretase dependency and specificity of these responses. Together, these data strengthen the rationale for using gamma-secretase inhibitors therapeutically and suggest that programmed cell death may contribute to reduction of tumor burden in the clinic.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17317574 DOI: 10.1016/j.chembiol.2006.12.010
Source DB: PubMed Journal: Chem Biol ISSN: 1074-5521